HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity.

Abstract
Water-soluble corroles with inherent fluorescence can form stable self-assemblies with tumor-targeted cell penetration proteins, and have been explored as agents for optical imaging and photosensitization of tumors in pre-clinical studies. However, the limited tissue-depth of excitation wavelengths limits their clinical applicability. To examine their utility in more clinically-relevant imaging and therapeutic modalities, here we have explored the use of corroles as contrast enhancing agents for magnetic resonance imaging (MRI), and evaluated their potential for tumor-selective delivery when encapsulated by a tumor-targeted polypeptide. We have found that a manganese-metallated corrole exhibits significant T1 relaxation shortening and MRI contrast enhancement that is blocked by particle formation in solution but yields considerable MRI contrast after tissue uptake. Cell entry but not low pH enables this. Additionally, the corrole elicited tumor-toxicity through the loss of mitochondrial membrane potential and cytoskeletal breakdown when delivered by the targeted polypeptide. The protein-corrole particle (which we call HerMn) exhibited improved therapeutic efficacy compared to current targeted therapies used in the clinic. Taken together with its tumor-preferential biodistribution, our findings indicate that HerMn can facilitate tumor-targeted toxicity after systemic delivery and tumor-selective MR imaging activatable by internalization.
AuthorsJessica D Sims, Jae Youn Hwang, Shawn Wagner, Felix Alonso-Valenteen, Chris Hanson, Jan Michael Taguiam, Richard Polo, Ira Harutyunyan, Gevorg Karapetyan, Karn Sorasaenee, Ahmed Ibrahim, Eduardo Marban, Rex Moats, Harry B Gray, Zeev Gross, Lali K Medina-Kauwe
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 217 Pg. 92-101 (Nov 10 2015) ISSN: 1873-4995 [Electronic] Netherlands
PMID26334483 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Contrast Media
  • Neuregulin-1
  • Porphyrins
  • Recombinant Fusion Proteins
  • corrole
  • Manganese
Topics
  • Animals
  • Antineoplastic Agents (pharmacokinetics, pharmacology, therapeutic use)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Contrast Media (pharmacokinetics, pharmacology, therapeutic use)
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Manganese (pharmacokinetics, pharmacology, therapeutic use)
  • Mice, Nude
  • Neoplasms (drug therapy, metabolism, pathology)
  • Neuregulin-1 (pharmacokinetics, pharmacology, therapeutic use)
  • Porphyrins (pharmacokinetics, pharmacology, therapeutic use)
  • Recombinant Fusion Proteins (pharmacokinetics, pharmacology, therapeutic use)
  • Tissue Distribution
  • Tumor Burden (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: